$2.26T
Total marketcap
$423.07B
Total volume
BTC 55.45%     ETH 9.36%
Dominance

PURE Bioscience PURE Stock

$0.06   -14.285716%
Add to favorites
Market Cap
$7.80M
LOW - HIGH [24H]
$0.06 - $0.07
VOLUME [24H]
$81.53K
P/E Ratio
0
Earnings per share
-$0.02
ISIN
US74621T2096

PURE Bioscience Price Chart

Sorry, that's all we've gotfor now...

PURE Bioscience PURE Financial and Trading Overview

PURE Bioscience stock price 0.06 USD
Previous Close 0.08 USD
Open 0.08 USD
Bid 0.07 USD x 2000000
Ask 0.07 USD x 1000000
Day's Range 0.07 - 0.08 USD
52 Week Range 0.04 - 0.14 USD
Volume 10.9K USD
Avg. Volume 41.52K USD
Market Cap 9.1M USD
Beta (5Y Monthly) 0.106
PE Ratio (TTM) N/A
EPS (TTM) -0.02 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

PURE Valuation Measures

Enterprise Value 13.78M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) 1.03
Price/Sales (ttm) 3.7811508
Price/Book (mrq) N/A
Enterprise Value/Revenue 5.725
Enterprise Value/EBITDA -6.963

Trading Information

PURE Bioscience Stock Price History

Beta (5Y Monthly) 0.106
52-Week Change -30.00000000000000000000000000000000%
S&P500 52-Week Change 27.29%
52 Week High 0.14 USD
52 Week Low 0.04 USD
50-Day Moving Average 0.08 USD
200-Day Moving Average 0.07 USD

PURE Share Statistics

Avg. Volume (3 month) 41.52K USD
Avg. Daily Volume (10-Days) 45.86K USD
Shares Outstanding 130.02M
Float 72.16M
Short Ratio 2.56
% Held by Insiders 41.25%
% Held by Institutions 0%
Shares Short 222.97K
Short % of Float 1.85%
Short % of Shares Outstanding 1.82%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:8

Financial Highlights

Fiscal Year

Fiscal Year Ends July 31, 2025
Most Recent Quarter (mrq) January 31, 2026
Next Fiscal Year End July 31, 2026

Profitability

Profit Margin -89.77%
Operating Margin (ttm) -153.82%
Gross Margin 59.78%
EBITDA Margin -82.21%

Management Effectiveness

Return on Assets (ttm) -181.90%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 2.41M USD
Revenue Per Share (ttm) 0.02 USD
Quarterly Revenue Growth (yoy) 13.60%
Gross Profit (ttm) 1.44M USD
EBITDA -1979000 USD
Net Income Avi to Common (ttm) -2161000 USD
Diluted EPS (ttm) -0.02
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 198K USD
Total Cash Per Share (mrq) 0.002 USD
Total Debt (mrq) 6.15M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.255
Book Value Per Share (mrq) -0.056

Cash Flow Statement

Operating Cash Flow (ttm) -1824000 USD
Levered Free Cash Flow (ttm) -1478000 USD

Profile of PURE Bioscience

Country United States
State CA
City El Cajon
Address 771 Jamacha Rd., #512
ZIP 92019
Phone 619 596 8600
Website https://www.purebio.com
Industry Household & Personal Products
Sector(s) Consumer Defensive
Full Time Employees 11

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company's technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products. The company serves food processing, food service and hospitality, healthcare, facility care, transportation, and personal care industries. It sells its products through end-use customers and third-party distributors. The company was incorporated in 1992 and is based in El Cajon, California.

Q&A For PURE Bioscience Stock

What is a current PURE stock price?

PURE Bioscience PURE stock price today per share is 0.06 USD.

How to purchase PURE Bioscience stock?

You can buy PURE shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for PURE Bioscience?

The stock symbol or ticker of PURE Bioscience is PURE.

Which industry does the PURE Bioscience company belong to?

The PURE Bioscience industry is Household & Personal Products.

How many shares does PURE Bioscience have in circulation?

The max supply of PURE Bioscience shares is 130.02M.

What is PURE Bioscience Price to Earnings Ratio (PE Ratio)?

PURE Bioscience PE Ratio is now.

What was PURE Bioscience earnings per share over the trailing 12 months (TTM)?

PURE Bioscience EPS is -0.02 USD over the trailing 12 months.

Which sector does the PURE Bioscience company belong to?

The PURE Bioscience sector is Consumer Defensive.

Select currency